HELP     Sign In
Search

Relevance to Autism

Rare mutations in the GRID2 gene have been identified with ASD (Schaaf et al., 2011). In particular, that study found two non-synonymous SNPs in GRID2 in 3 of 339 individuals with ASD.

Molecular Function

Human glutamate receptor delta-2 (GRID2) is a relatively new member of the family of ionotropic glutamate receptors which are the predominant excitatory neurotransmitter receptors in the mammalian brain. GRID2 is a predicted 1,007 amino acid protein that shares 97% identity with the mouse homolog which is expressed selectively in cerebellar Purkinje cells. GRID2 is strongly suggested to have a role in neuronal apoptotic death.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders.
ASD
Positive Association
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with ...
ASD
Support
Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder.
ASD
Support
A discovery resource of rare copy number variations in individuals with autism spectrum disorder.
ASD
Support
Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy.
Epilepsy
Support
Mutational Landscape of Autism Spectrum Disorder Brain Tissue
ASD
Support
Neurodevelopmental Syndrome with Intellectual Disability, Speech Impairment, and Quadrupedia Is Associated with Glutamate Receptor Delta 2 Gene Defect
DD, ID, epilepsy/seizures
Support
Identification of genetic causes of congenital neurodevelopmental disorders using genome wide molecular technologies.
ASD, DD
Support
Synaptic, transcriptional and chromatin genes disrupted in autism.
ASD
Recent Recommendation
Deletions in GRID2 lead to a recessive syndrome of cerebellar ataxia and tonic upgaze in humans.
DD, ID
Recent Recommendation
A homozygous deletion in GRID2 causes a human phenotype with cerebellar ataxia and atrophy.
DD

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN283R001 
 missense_variant 
 c.1190C>T 
 p.Pro397Leu 
 Familial 
 Paternal 
 Simplex 
 GEN283R002 
 missense_variant 
 c.1933G>A 
 p.Val645Ile 
 Familial 
 Paternal 
 Simplex 
 GEN283R003 
 synonymous_variant 
 c.1803G>A 
 p.Thr601= 
 Unknown 
  
 Unknown 
 GEN283R004 
 missense_variant 
 c.2921T>A 
 p.Phe974Tyr 
 Unknown 
  
 Unknown 
 GEN283R005 
 intron_variant 
 G>A 
  
 Unknown 
  
 Unknown 
 GEN283R006 
 copy_number_loss 
  
  
 Unknown 
  
 Unknown 
 GEN283R007 
 copy_number_loss 
  
  
 Unknown 
  
 Unknown 
 GEN283R008 
 copy_number_loss 
  
  
 Unknown 
  
 Unknown 
 GEN283R009 
 copy_number_loss 
  
  
 Unknown 
  
 Unknown 
 GEN283R010 
 copy_number_loss 
  
  
 Unknown 
  
 Unknown 
 GEN283R011 
 copy_number_loss 
  
  
 Unknown 
  
 Unknown 
 GEN283R012 
 copy_number_loss 
  
  
 Unknown 
  
 Unknown 
 GEN283R013 
 copy_number_loss 
  
  
 Unknown 
  
 Unknown 
 GEN283R014 
 copy_number_gain 
  
  
 De novo 
  
 Multiplex 
 GEN283R015 
 copy_number_loss 
  
  
 Familial 
 Paternal 
 Simplex 
 GEN283R016a 
 copy_number_loss 
  
  
 Familial 
 Both parents 
 Extended multiplex 
 GEN283R017a 
 copy_number_loss 
  
  
 Familial 
 Both parents 
 Extended multiplex 
 GEN283R018a 
 copy_number_loss 
  
  
 De novo 
  
 Simplex 
 GEN283R018b 
 copy_number_loss 
  
  
 Familial 
 Maternal 
 Simplex 
 GEN283R019 
 missense_variant 
 c.1777C>G 
 p.Pro593Ala 
 De novo 
  
  
 GEN283R020 
 copy_number_loss 
  
  
 Familial 
 Paternal 
  
 GEN283R021a 
 copy_number_loss 
  
  
 Familial 
 Both parents 
 Multiplex 
 GEN283R022 
 synonymous_variant 
 c.2364C>T 
 p.Ile788%3D 
 Unknown 
  
  

Common

Variant ID
Polymorphism
SNP ID
Allele Change
Residue Change
Population Origin
Population Stage
Author, Year
 GEN283C001 
 intron_variant 
 rs6854329 
 c.244+85419G>C 
  
 7387 ASD cases and 8567 controls from Autism Center of Excellence Network (ACE), Autism Genetic Resource Exchange (AGRE), Autism Genome Project (AGP), Finnish Case-Control ASD Collection, NIMH Repository and Montreal/Boston (MonBos) Collection, Population-Based Autism Genetics and Environment Study (PAGES), Simons Simplex Collection (SSC), and Weiss Laboratory Autism Collection 
 Discovery 
 GEN283C002 
 intron_variant 
 rs6811974 
 c.245-47461T>C;c.245-21708T>C;c.281-21708T>C 
  
 7387 ASD cases and 8567 controls from Autism Center of Excellence Network (ACE), Autism Genetic Resource Exchange (AGRE), Autism Genome Project (AGP), Finnish Case-Control ASD Collection, NIMH Repository and Montreal/Boston (MonBos) Collection, Population-Based Autism Genetics and Environment Study (PAGES), Simons Simplex Collection (SSC), and Weiss Laboratory Autism Collection 
 Discovery 
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
4
Duplication
 1
 
4
Deletion
 1
 
4
Deletion
 1
 
4
Deletion-Duplication
 25
 
4
Duplication
 4
 
4
Deletion-Duplication
 15
 
4
Duplication
 1
 

Model Summary

Grid2 loss of function mutation leads to ataxia and cerebellar disorders along with eye movement abnormalities.

References

Type
Title
Author, Year
Primary
Deletions in GRID2 lead to a recessive syndrome of cerebellar ataxia and tonic upgaze in humans.

M_GRID2_1_SP_DEL

Model Type: Genetic
Model Genotype: Homozygous
Mutation: There is a spontaneous in frame deletion of exon 2 of the Grid2 gene in these mice. They are also called ho-15J.
Allele Type: Spontaneous
Strain of Origin: C3Fe.Cg-scb/J
Genetic Background: C3(Cg)-Grid2ho-15J/GrsrJ
ES Cell Line:
Mutant ES Cell Line:
Model Source:

M_GRID2_2_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: The cre sequence and an FRT-flanked neo cassette were inserted at the start codon.
Allele Type: Targeted(Knock-in)
Strain of Origin: C57BL/6N
Genetic Background: C57BL/6
ES Cell Line: RENKA
Mutant ES Cell Line:
Model Source:

M_GRID2_1_SP_DEL

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Spontaneous and reflexive eye movements1
Abnormal
Description: Ho-15j mice show larger spontaneous and random eye movements compared to littermate controls
Exp Paradigm: Eye movements were monitored using an infrared camera under room light conditions
 Eye movement recording
 >7 weeks
Ataxia1
Increased
Description: Ho-15j mice show increased ataxia
Exp Paradigm: NA
 NA
 Unreported
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_GRID2_2_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Spontaneous and reflexive eye movements1
Abnormal
Description: Grid2 null mice show larger spontaneous eye movements than littermates
Exp Paradigm: Eye movements were monitored using an infrared camera under room light conditions
 Eye movement recording
 >7 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
GRIK2 glutamate receptor, ionotropic, kainate 2 2898 Q13002 IP/WB
Kohda K , et al. 2003
Camk2b calcium/calmodulin-dependent protein kinase II, beta 12323 P28652 IP; LC-MS/MS
Uemura T , et al. 2010
Cbln1 cerebellin 1 precursor 12404 Q9R171 IP; LC-MS/MS; Cell surface binding assay; Cell aggregation assay; in vitro binding assay; Surface plasmon resonance (SPR)
Uemura T , et al. 2010
Cnp 2',3'-cyclic nucleotide 3' phosphodiesterase 12799 P16330 IP; LC-MS/MS
Uemura T , et al. 2010
Eci2 enoyl-Coenzyme A delta isomerase 2 23986 Q9WUR2 IP; LC-MS/MS
Uemura T , et al. 2010
Fat2 FAT tumor suppressor homolog 2 (Drosophila) 245827 Q5F226 IP; LC-MS/MS
Uemura T , et al. 2010
Gapdh glyceraldehyde-3-phosphate dehydrogenase 14433 P16858 IP; LC-MS/MS
Uemura T , et al. 2010
Hnrnpa1 heterogeneous nuclear ribonucleoprotein A1 15382 P49312 IP; LC-MS/MS
Uemura T , et al. 2010
Idh3b isocitrate dehydrogenase 3 (NAD+) beta 170718 Q91VA7 IP; LC-MS/MS
Uemura T , et al. 2010
Nrxn1 neurexin 1 18189 Q9CS84 IP; LC-MS/MS; Cell surface binding assay; Cell aggregation assay; in vitro binding assay
Uemura T , et al. 2010
Nrxn2 neurexin II 18190 E9Q7X7 IP; LC-MS/MS; Cell surface binding assay; Cell aggregation assay
Uemura T , et al. 2010
Ptprs protein tyrosine phosphatase, receptor type, S 19280 B0V2N1 IP; LC-MS/MS
Uemura T , et al. 2010
SHANK2 SH3/ankyrin domain gene 2 210274 Q80Z38 Y2H; IP/WB; GST; Surface plasmon resonance (SPR)
Uemura T , et al. 2004
Srcin1 SRC kinase signaling inhibitor 1 56013 Q9QWI6 IP; LC-MS/MS
Uemura T , et al. 2010
Tprn taperin 97031 A2AI08 IP; LC-MS/MS
Uemura T , et al. 2010
Ttc9b tetratricopeptide repeat domain 9B 73032 Q9D6E4 IP; LC-MS/MS
Uemura T , et al. 2010
Vim vimentin 22352 P20152 IP; LC-MS/MS
Uemura T , et al. 2010

HELP
Copyright © 2017 MindSpec, Inc.